We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Examines outcomes of complete responders after fixed-duration glofitamab for relapsed large B-cell lymphoma, suggesting effective treatment strategies.
No takes yet. Share an insight, caveat, or question.
Shumilov et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: